REVIEW
Published on 16 Dec 2024
What are clinically significant anti-drug antibodies and why is it important to identify them
doi 10.3389/fimmu.2024.1401178
- 282 views
- Frontiers in Immunology
- B Cell Biology
- Research Topics
- The Immune Response to Therapeutic Antibodies
The Immune Response to Therapeutic Antibodies
7,989
Total downloads
36k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 11 Nov 2024
Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development
doi 10.3389/fimmu.2024.1438251
- 744 views
ORIGINAL RESEARCH
Published on 22 Aug 2024
Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays
doi 10.3389/fimmu.2024.1429544
- 1,157 views
ORIGINAL RESEARCH
Published on 20 Aug 2024
Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics
doi 10.3389/fimmu.2024.1406804
- 1,412 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 Jul 2024
Comparison of “framework Shuffling” and “CDR Grafting” in humanization of a PD-1 murine antibody
doi 10.3389/fimmu.2024.1395854
- 2,586 views
- 1 citation
ORIGINAL RESEARCH
Published on 31 May 2024
Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure
doi 10.3389/fimmu.2024.1406353
- 1,778 views
ORIGINAL RESEARCH
Published on 28 May 2024
Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays
doi 10.3389/fimmu.2024.1406040
- 1,974 views
ORIGINAL RESEARCH
Published on 15 May 2024
Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis
doi 10.3389/fimmu.2024.1377911
- 1,552 views
- 1 citation
REVIEW
Published on 15 May 2024
Prospects for the computational humanization of antibodies and nanobodies
doi 10.3389/fimmu.2024.1399438
- 4,408 views
- 4 citations
CORRECTION
Published on 27 Feb 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α
doi 10.3389/fimmu.2024.1383704
- 505 views
ORIGINAL RESEARCH
Published on 26 Jan 2024
Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein
doi 10.3389/fimmu.2024.1345473
- 3,834 views
ORIGINAL RESEARCH
Published on 23 Jan 2024
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α
doi 10.3389/fimmu.2024.1342477
- 1,047 views
Published in
Frontiers in Immunology
- B Cell Biology
Impact
- 36kTopic views
- 26kArticle views
- 7,989Article downloads